Dr Michelle Miller is the CEO of Biotron which has an HIV drug. The company hit the jackpot in September with a phase two trial result that took the share price from 2 cents to 30 cents. Alan Kohler spoke to Dr Miller to find out more.
Alan Kohler is one of Australia’s most respected finance reporters. For decades readers and viewers have enjoyed his expert opinion in press, television and of course on line. His writing and interviews bring a context to the issues that matter to investors, with a personality that is often missing from other financial experts. Alan started The Constant Investor to be able to directly share his passion for discovering exciting companies.